Regfo
Module 1administrativendaind

1.4 — References

Letters of authorization, right of reference statements, and cross-references to other applications

Requirements by Phase

Phase 1
optional
Phase 2
optional
Phase 3
optional
NDA
required

Letters of authorization, right of reference statements, and cross-references to other applications

Requirements by Phase

IND Phase 1: optional IND Phase 2: optional IND Phase 3: optional NDA: required

Content Requirements

  • Letters of authorization from referenced application holders
  • Right of reference statements
  • List of authorized studies with study identifiers
  • Cross-references to other INDs, NDAs, DMFs, or master files

Expected Deliverables

  • Letters of authorization
  • Right of reference statements
  • Cross-reference list

ICH Guidelines: 21 CFR 312.23

Source: 21 CFR 312.23

References

Check your compliance against this section

Upload your study data and get instant gap analysis with specific regulatory citations.

Try Compliance Check